NCT06492070 - Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Cervical CarcinomaFallopian Tube CarcinomaMalignant Solid NeoplasmMalignant Uterine NeoplasmOvarian CarcinomaPrimary Peritoneal CarcinomaVulvar Carcinoma

Interventions

OTHER

Best Practice

Undergo standard of care

DRUG

Cilostazol

Given PO

DEVICE

Cryocompression Therapy

Undergo cryocompression therapy

DRUG

Paclitaxel

Given by infusion

OTHER

Quality-of-Life Assessment

Ancillary studies

Trial Locations (3)

30308

RECRUITING

Emory University Hospital Midtown, Atlanta

30322

NOT_YET_RECRUITING

Emory University Hospital/Winship Cancer Institute, Atlanta

30342

NOT_YET_RECRUITING

Emory Saint Joseph's Hospital, Atlanta

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER